Esophageal pH and Impedance Monitoring



Gastro Esophageal Reflux Disease (GERD) is most common and affects a significant part of the population. It is a multifactorial condition, with a wide clinical expression. Heartburn is the most common symptom, but other complaints such as acid regurgitation, dysphagia, and also atypical complaints: coughs, asthma and laryngitis can be caused by this pathology. Several diagnostic tests, including clinical trials, imaging techniques, endoscopies, esophageal manometry and reflux evaluation, are available. All of them have advantages and disadvantages. Several treatments are available for this disease, a lifestyle modification, medical, as well as surgical therapies. Wise use, proper question, knowing the limitations of various methods will help accurate diagnosis and optimal treatment matching.


Proton Pump Inhibitor Therapy Reflux Episode Esophageal Acid Exposure Reflux Event Proton Pump Inhibitor Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Allison PR. Peptic ulcer of the esophagus. J Thorac Cardiovasc Surg. 1946;15:308–17.Google Scholar
  2. 2.
    Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.PubMedGoogle Scholar
  3. 3.
    Serag HB. Time trends for gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5:17–26.PubMedGoogle Scholar
  4. 4.
    Gallup Organization. A Gallup Organization National Survey: heartburn across America. Princeton: The Gallup Organization; 1988.Google Scholar
  5. 5.
    Locke GR, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448.PubMedGoogle Scholar
  6. 6.
    Moayyedi P, Axon ATR. Gastro-oesophageal reflux disease: the extent of the problem. Aliment Pharmacol Ther. 2005;22 Suppl 1:11–9.PubMedGoogle Scholar
  7. 7.
    Hu WH, Hui WM, Lam CL, Lam SK. Anxiety and depression are co-factors determining health care utilisation in patients with dyspepsia: a Hong Kong population based study. Gastroenterology. 1997;112 Suppl 1:A153.Google Scholar
  8. 8.
    Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med. 1982;307:1547–52.PubMedGoogle Scholar
  9. 9.
    Dent J, Dodds WJ, Friedman RH, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980;65:256–67.PubMedGoogle Scholar
  10. 10.
    Kahrilas PJ, Shi G, Manka M, Joehl RJ. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distension in reflux patients with hiatal hernia. Gastroenterology. 2000;118:688–95.PubMedGoogle Scholar
  11. 11.
    de Vries DR, van Herwaarden MA, Smout AJ, Samsom M. Gastroesophageal pressure gradients in gastroesophageal reflux disease: relations with hiatal hernia, body mass index, and esophageal acid exposure. Am J Gastroenterol. 2008;103:1349–54.PubMedGoogle Scholar
  12. 12.
    Corley DA, Kubo A, Levin TR, et al. Abdominal obesity and body mass index as risk factors for Barrett’s esophagus. Gastroenterology. 2007;133:34–41.PubMedGoogle Scholar
  13. 13.
    Kahrilas PJ. GERD pathogenesis, pathophysiology and clinical manifestations. Cleve Clin J Med. 2003;70 Suppl 5:S4–19.PubMedGoogle Scholar
  14. 14.
    Blackshaw LA. Receptors and transmission in the brain-gut axis: potential for novel therapies. IV. GABA(B) receptors in the brain-gastroesophageal axis. Am J Physiol Gastrointest Liver Physiol. 2001;281:G311–5.PubMedGoogle Scholar
  15. 15.
    Hirsch DP, Tytgat GN, Boeckxstaens GE. Transient lower oesophageal sphincter relaxations: a pharmacological target for gastro-oesophageal reflux disease? Aliment Pharmacol Ther. 2002;16:17–26.PubMedGoogle Scholar
  16. 16.
    Penagini R, Carmagnola S, Cantu P, et al. Mechanoreceptors of the proximal stomach: role in triggering transient lower esophageal sphincter relaxation. Gastroenterology. 2004;126:49–56.PubMedGoogle Scholar
  17. 17.
    Dent J. Patterns of lower esophageal sphincter function associated with gastroesphageal reflux. Am J Med. 1997;103(Suppl 5A):29S–32S.PubMedGoogle Scholar
  18. 18.
    Wajed SA, Streets CG, Bremner CG, DeMeester TR. Elevated body mass disrupts the barrier to gastroesophageal reflux. Arch Surg. 2001;136:1014–8.PubMedGoogle Scholar
  19. 19.
    Kahrilas PJ, Lin S, Chen J, et al. The effect of hiatus hernia on gastrooesophageal junction pressure. Gut. 1999;44:476–82.PubMedGoogle Scholar
  20. 20.
    van Herwaarden MA, Samsom M, Smout AJ. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology. 2000;119:1439–46.PubMedGoogle Scholar
  21. 21.
    Barak N, Ehrenpreis ED, Harrison JR, Sitrin MD. Gastro-oesophageal reflux disease in obesity: pathophysiology and therapeutic considerations. Obes Rev. 2002;3:9–15.PubMedGoogle Scholar
  22. 22.
    Kahrilas PJ, Gupta RR. Mechanisms of acid reflux associated with cigarette smoking. Gut. 1990;31:4–10.PubMedGoogle Scholar
  23. 23.
    Vitale GC, Cheadle WG, Patel B, Sadek SA, Michel ME, Cuschieri A. The effect of alcohol on nocturnal gastroesophageal reflux. JAMA. 1987;258:2077–9.PubMedGoogle Scholar
  24. 24.
    Thomas FB, Steinbaugh JT, Fromkes JJ, Mekhjian HS, Caldwell JH. Inhibitory effect of coffee on lower esophageal sphincter pressure. Gastroenterology. 1980;79:1262–6.PubMedGoogle Scholar
  25. 25.
    Holloway RH, Lyrenas E, Ireland A, Dent J. Effect of intraduodenal fat on lower oesophageal sphincter function and gastro-oesophageal reflux. Gut. 1997;40:449–53.PubMedGoogle Scholar
  26. 26.
    Carlsson R, Dent J, Bolling-Sternevold E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023.PubMedGoogle Scholar
  27. 27.
    Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003;98:1487.PubMedGoogle Scholar
  28. 28.
    Fass R, Naliboff BD, Fass SS, et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology. 2008;134:696–705.PubMedGoogle Scholar
  29. 29.
    Schey R, Dickman R, Parthasarathy S, et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:1787–95.PubMedGoogle Scholar
  30. 30.
    Wright CE, Ebrecht M, Mitchell R, et al. The effect of psychological stress on symptom severity and perception in patients with gastro-oesophageal reflux. J Psychosom Res. 2005;59:415–24.PubMedGoogle Scholar
  31. 31.
    Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology. 2004;126:660–4.PubMedGoogle Scholar
  32. 32.
    Jacob P, Kahrilas PJ, Vanagunos A. Peristaltic dysfunction associated with non-obstructive dysphagia in reflux disease. Dig Dis Sci. 1990;35:939.PubMedGoogle Scholar
  33. 33.
    Brzana RJ, Koch KL. Gastroesophageal reflux disease presenting with intractable nausea. Ann Intern Med. 1997;126:704.PubMedGoogle Scholar
  34. 34.
    Richter JE. Extraesophageal presentations of gastroesophageal reflux disease. Am J Gastroenterol. 2000;25:S1.Google Scholar
  35. 35.
    DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190–200.PubMedGoogle Scholar
  36. 36.
    Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults—update 2004. Can J Gastroenterol. 2005;19:15–35.PubMedGoogle Scholar
  37. 37.
    Kahrilas PJ, Shaheen NJ, Vaezi M, et al. AGAI medical position statement: management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383–91.PubMedGoogle Scholar
  38. 38.
    Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004;140:518–27.PubMedGoogle Scholar
  39. 39.
    Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophagal reflux disease. Yale J Biol Med. 1999;72:81–92.PubMedGoogle Scholar
  40. 40.
    Richter JE. Severe reflux esophagitis. Gastrointest Endosc Clin N Am. 1994;4:677.PubMedGoogle Scholar
  41. 41.
    Terea L, Fein M, Ritter MP, et al. Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease? Am Surg. 1997;63:933–6.Google Scholar
  42. 42.
    Vakil NB, Traxler B, Levine D. Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment. Clin Gastroenterol Hepatol. 2004;2:665–8.PubMedGoogle Scholar
  43. 43.
    Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.PubMedGoogle Scholar
  44. 44.
    Dent J. Microscopic esophageal mucosal injury in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2007;5:4–16.PubMedGoogle Scholar
  45. 45.
    Sharma P, Wani S, Rastogi A, et al. The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett’s esophagus: a blinded, prospective study. Am J Gastroenterol. 2008;103:525–32.PubMedGoogle Scholar
  46. 46.
    Galmish JP, Sacher-Huvelin S, Coron E, et al. Screening for esophagitis and Barrett’s esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial with reflux symptoms. Am J Gastroenterol. 2008;103:528–45.Google Scholar
  47. 47.
    Thompson JK, Koehler RE, Richter JE. Detection of gastro-esophageal reflux: value of the barium studies compared with 24-hour pH monitoring. Am J Roentgenol. 1994;162:621.Google Scholar
  48. 48.
    Johnston BT, Troshinsky MB, Castell JA, Castell DO. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol. 1996;91:1181.PubMedGoogle Scholar
  49. 49.
    Waring JP, Hunter JG, Oddsdottir M. The preoperative evaluation of patients considered for laparoscopic antireflux surgery. Am J Gastroenterol. 1995;90:35.PubMedGoogle Scholar
  50. 50.
    Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383–413.PubMedGoogle Scholar
  51. 51.
    Kenneth R, DeVault DOC. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190–200.Google Scholar
  52. 52.
    DeMeester TR, Peters JH, Bremner CG, et al. Biology of gastroesophageal reflux disease: pathophysiology relating to medical and surgical treatment. Annu Rev Med. 1999;50:469–506.PubMedGoogle Scholar
  53. 53.
    Carlsson R, Galmiche JP, Dent J, et al. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther. 1997;11:473–82.PubMedGoogle Scholar
  54. 54.
    Fass R, Murthy U, Hayden CW, et al. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy: a prospective, randomized, multi-centre study. Aliment Pharmacol Ther. 2000;14:1595–603.PubMedGoogle Scholar
  55. 55.
    Spencer J. Prolonged pH recording in the study of gastroesophageal reflux. Br J Surg. 1969;56:9–12.Google Scholar
  56. 56.
    Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol. 1974;62:325–32.PubMedGoogle Scholar
  57. 57.
    Hirano I, Richter JE. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–85.PubMedGoogle Scholar
  58. 58.
    Booth MI, Stratford J, Dehn TCB. Patient self-assessment of test-day symptoms in 24 hour pH metry for suspected gastroesophageal reflux disease. Scand J Gastroenterol. 2001;36:795.PubMedGoogle Scholar
  59. 59.
    McLauchlan G, Rawlings JM, Lucas ML, et al. Electrodes for 24 hour pH monitoring: a comparative study. Gut. 1987;28:935–9.PubMedGoogle Scholar
  60. 60.
    Smout AJPM. Ambulatory monitoring of esophageal pH and pressure. In: Castell DO, Richter JE, editors. The esophagus. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1999. p. 119–33.Google Scholar
  61. 61.
    Kahrilas PJ, Quigley EMM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology. 1996;100:1982–96.Google Scholar
  62. 62.
    McLauchlan G, Rawlings JM, Lucas ML, McCloy RF, Crean GP, McColl KE. Electrodes for 24 hours pH monitoring-a comparative study. Gut. 1987;28:935–9.PubMedGoogle Scholar
  63. 63.
    Kahrilas PJ, Quigley EMM. Clinical esophageal pH recording: a technical review for practice guidelines development. Gastroenterology. 1996;110:1982–96.PubMedGoogle Scholar
  64. 64.
    Chiocca JC, Olmos JA, Salis GB, Soifer LO, Higa R, Marcolongo M. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study. Aliment Pharmacol Ther. 2005;22:331–42.PubMedGoogle Scholar
  65. 65.
    Wenner J, Johnsson F, Johansson J, Oberg S. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol. 2007;102:239–45.PubMedGoogle Scholar
  66. 66.
    Pandolfino JE, Kahrilas JP. Prolonged pH monitoring: Bravo capsule. Gastrointest Endosc Clin N Am. 2005;15:307–18.PubMedGoogle Scholar
  67. 67.
    Tseng D, Rizvi A, Fennerty MB, et al. Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastroenterol Surg. 2005;9(8):1043–52.Google Scholar
  68. 68.
    Pandolfino JE, Schreiner MA, Lee TJ, et al. Comparison of the Bravo wireless and Digitrapper catheter-based pH monitoring systems for measuring esophageal acid exposure. Am J Gastroenterol. 2005;100:1466–76.PubMedGoogle Scholar
  69. 69.
    Pandolfino JE, Zhang Q, Schreiner MA, et al. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different? Gut. 2005;54:1687–92.PubMedGoogle Scholar
  70. 70.
    des Varannes SB, Mion F, Ducrotte P, et al. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut. 2005;54:1682–6.PubMedGoogle Scholar
  71. 71.
    Pandolfino JE, Richter JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003;98:740–9.PubMedGoogle Scholar
  72. 72.
    Richter JE, Bradley LA, DeMeester TR, et al. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci. 1992;37:849–56.PubMedGoogle Scholar
  73. 73.
    Wong WM, Bautista J, Dekel R, et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring: a randomized trial. Aliment Pharmacol Ther. 2005;21:155–63.PubMedGoogle Scholar
  74. 74.
    Sweis R, Fox M, Anggiansah R, et al. Patient acceptance and clinical impact of Bravo monitoring in patients with previously failed catheter-based studies. Aliment Pharmacol Ther. 2009;29:669–76.PubMedGoogle Scholar
  75. 75.
    Fass R. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Clin Cornerstone. 1999;1:1–17.PubMedGoogle Scholar
  76. 76.
    Prakash C, Jonnalagadda S, Azar R, et al. Endoscopic removal of the wireless pH monitoring capsule in patients with severe discomfort. Gastrointest Endosc. 2006;64:828–32.PubMedGoogle Scholar
  77. 77.
    Bhat YM, McGrath KM, Bielefeldt K. Wireless esophageal pH monitoring: new technique means new questions. J Clin Gastroenterol. 2006;40:116–21.PubMedGoogle Scholar
  78. 78.
    Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005;100:283–9.PubMedGoogle Scholar
  79. 79.
    Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil. 1991;3:151–62.Google Scholar
  80. 80.
    Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–31.PubMedGoogle Scholar
  81. 81.
    Bredenoord AJ, Weusten BL, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut. 2006;55:313–8.PubMedGoogle Scholar
  82. 82.
    Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99:1037–43.PubMedGoogle Scholar
  83. 83.
    Zerbib F, Bruley des Barannes S, Roman S, et al. 24 hour ambulatory esophageal multichannel intraluminal impedance-pH in healthy European subjects. Gastroenter­ology. 2005;128:A396.Google Scholar
  84. 84.
    Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001;120:1588–98.PubMedGoogle Scholar
  85. 85.
    Bredenoord AJ, Weusten BL, Timmer R, et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol. 2006;101:453–9.PubMedGoogle Scholar
  86. 86.
    Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001;120:1599–606.PubMedGoogle Scholar
  87. 87.
    Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy. A multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–402.PubMedGoogle Scholar
  88. 88.
    Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD. A study in patients off and on therapy. Am J Gastroenterol. 2006;101:1956–63.PubMedGoogle Scholar
  89. 89.
    Park W, Vaezi M. Esophageal impedance recording: clinical utility and limitations. Curr Gastroenterol Rep. 2005;7:182–9.PubMedGoogle Scholar
  90. 90.
    Sifrim D, Blondeau K. Technology insight: the role of impedance testing for esophageal disorders. Nat Clin Pract Gastroenterol Hepatol. 2006;3:210–9.PubMedGoogle Scholar
  91. 91.
    Tutuian R, Castell D. Review article complete gastro-oesophageal reflux monitoring—combined pH and impedance. Aliment Pharmacol Ther. 2006;24 Suppl 2:27–37.PubMedGoogle Scholar
  92. 92.
    Agrawal A, Castell D. Clinical importance of impedance measurements. J Clin Gastroenterol. 2008;42:579–83.PubMedGoogle Scholar
  93. 93.
    Bredenoord A, Tutuian R, Andre J, et al. Technology review: esophageal impedance monitoring. Am J Gastroenterol. 2007;102:187–94.PubMedGoogle Scholar
  94. 94.
    Shay S. Esophageal impedance monitoring: the ups and downs of a new test. Am J Gastroenterol. 2004;99:1020–2.PubMedGoogle Scholar
  95. 95.
    Weusten BL, Akkermans LM, vanBerge-Heneggouwen GP, Smout AJ. Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol. 1994;266:G357–62.Google Scholar
  96. 96.
    Weusten BLAM, Akkermans LMA, Vanberge-Henegouwen GP, et al. Dynamic characteristics of gastro-oesophageal reflux in ambulatory patients with gastro-oesophageal reflux disease and normal control subjects. Scand J Gastroenterol. 1995;30:731–7.PubMedGoogle Scholar
  97. 97.
    Sifrim D. Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease. Gut. 2005;54:175–8.PubMedGoogle Scholar
  98. 98.
    Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92:825–9.PubMedGoogle Scholar
  99. 99.
    Jacob P, Kahrilas PJ, Herzon G. Proximal esophageal pH-metry in patients with “reflux laryngitis”. Gastroenterology. 1991;100:305–10.PubMedGoogle Scholar
  100. 100.
    Ulualp SO, Toohill RJ, Shaker R. Pharyngeal acid reflux in patients with single and multiple otolaryngologic disorders. Otolaryngol Head Neck Surg. 1999;121:725–30.PubMedGoogle Scholar
  101. 101.
    Katz PO. Ambulatory intragastric pH monitoring: clinical laboratory to clinical practice. Rev Gastroenterol Disord. 2003;3 Suppl 4:S3–9.PubMedGoogle Scholar
  102. 102.
    Bell NJ, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 1992;50 Suppl 1:59–67.Google Scholar
  103. 103.
    Fackler WK, Ours TM, Vaezi MF, et al. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology. 2002;122:625–32.PubMedGoogle Scholar
  104. 104.
    Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD) a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope. 1991;101:1–78.PubMedGoogle Scholar
  105. 105.
    Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology. 1995;109:1575–82.PubMedGoogle Scholar
  106. 106.
    Dobhan R, Castell DO. Normal and abnormal proximal esophageal acid exposure results of ambulatory dual-probe pH monitoring. Am J Gastroenterol. 1999;88:25–9.Google Scholar
  107. 107.
    Patti MG, Debas HT, Pellegrini CA. Esophageal manometry and 24-hour pH monitoring in the diagnosis of pulmonary aspiration secondary to gastroesophageal reflux. Am J Surg. 1992;163:401–6.PubMedGoogle Scholar
  108. 108.
    Wilson JA, White A, von Haacke NP, et al. Gastroesophageal reflux and posterior laryngitis. Ann Otol Rhinol Laryngol. 1989;98:405–10.PubMedGoogle Scholar
  109. 109.
    Kuhn J, Toohill RJ, Ulualp SO, et al. Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope. 1998;108:1146–9.PubMedGoogle Scholar
  110. 110.
    Bove M, Ruth M, Cange L, Mansson I. 24-h pharyngeal pH monitoring in healthy volunteersa normative study. Scand J Gastroenterol. 2000;3:234–41.Google Scholar
  111. 111.
    Wiener GJ, Koufman JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol. 1989;84:1503–8.PubMedGoogle Scholar
  112. 112.
    Williams RB, Ali GN, Wallace KL, et al. Esophagopharyngeal acid regurgitation: dual pH monitoring criteria for its detection and insights into mechanisms. Gastroenterology. 1999;117:1051–61.PubMedGoogle Scholar
  113. 113.
    Wo JM, Jabbar A, Winstead W, et al. Hypopharyngeal pH monitoring artifact in detection of laryngopharyngeal reflux. Dig Dis Sci. 2002;47:2579–85.PubMedGoogle Scholar
  114. 114.
    Singh S, Bradley LA, Richter JE. Determinants of oesophageal ‘alkaline’ pH environment in controls and patients with gastro-oesophageal reflux disease. Gut. 1993;34:309–16.PubMedGoogle Scholar
  115. 115.
    Ours TM, Fackler WK, Richter JE, et al. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol. 2003;98:545–50.PubMedGoogle Scholar
  116. 116.
    Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 1996;111:1192–9.PubMedGoogle Scholar
  117. 117.
    Singh P, Taylor RH, Colin-Jones DG. Simultaneous two level oesophageal pH monitoring in healthy controls and patients with oesophagitiscomparison between two positions. Gut. 1994;35:304–8.PubMedGoogle Scholar
  118. 118.
    Lacy BE, O’Shana T, Hynes M, et al. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Am J Gastroenterol. 2007;102:24–32.PubMedGoogle Scholar
  119. 119.
    McCollough M, Jabbar A, Cacchione R, et al. Proximal sensor data from routine dual-sensor esophageal pH monitoring is often inaccurate. Dig Dis Sci. 2004;49:1607–11.PubMedGoogle Scholar
  120. 120.
    Walther B, DeMeester T. Placement of the esophageal pH electrode for 24 hour esophageal pH monitoring. In: DeMeester T, Skinner DB, editors. Esophageal disorders: pathophysiology and therapy. New York: Raven; 1985. p. 539–41.Google Scholar
  121. 121.
    Dhiman RK, Saraswat VA, Naik SR. Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications. Dig Dis Sci. 2002;47:241–50.PubMedGoogle Scholar
  122. 122.
    Dobhan R, Castell DO. Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with “24-hr” analysis. Dig Dis Sci. 1992;37:857–64.PubMedGoogle Scholar
  123. 123.
    Choiniere L, Miller L, Ilves R, et al. A simplified method of esophageal pH monitoring for assessment of gastroesophageal reflux. Ann Thorac Surg. 1983;36:596–603.PubMedGoogle Scholar
  124. 124.
    Fink SM, McCallum RW. The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux. JAMA. 1984;252:1160–4.PubMedGoogle Scholar
  125. 125.
    Galmiche JP, Guillard JF, Denis P, et al. A study of post-prandial oesophageal pH in healthy subjects and in patients with gastro-oesophageal reflux. Diagnostic value of a scoring index of acid reflux. Gastroenterol Clin Biol. 1980;4:531–9.PubMedGoogle Scholar
  126. 126.
    Johnsson F, Joelsson B. Reproducibility of ambulatory oesophageal pH monitoring. Gut. 1988;29:886–9.PubMedGoogle Scholar
  127. 127.
    Dalby K, Nielsen RG, Markoew S, et al. Reproducibility of 24-hour combined multiple intraluminal impedance (MII) and pH measurements in infants and children. Evaluation of a diagnostic procedure for gastroesophageal reflux disease. Dig Dis Sci. 2007;52:2159–65.PubMedGoogle Scholar
  128. 128.
    Dhiman RK, Saraswat VA, Mishra A, et al. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci. 1996;41:764–72.PubMedGoogle Scholar
  129. 129.
    Agrawal A, Tutuian R, Hila A, et al. Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci. 2005;50:1916–20.PubMedGoogle Scholar
  130. 130.
    Wo JM, Castell DO. Exclusion of meal periods from ambulatory 24-hour pH monitoring may improve diagnosis of esophageal acid reflux. Dig Dis Sci. 1994;39:1601–7.PubMedGoogle Scholar
  131. 131.
    Furuta T, Shirai N, Watanabe F, et al. Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole. Clin Pharmacol Ther. 2002;72:453–60.PubMedGoogle Scholar
  132. 132.
    Tutuian R, Vela M, Hill E, et al. Characteristics of symptomatic reflux episodes on acid suppressive therapy. Am J Gastroenterol. 2008;103:1090–6.PubMedGoogle Scholar
  133. 133.
    Zerbib F, Duriez A, Roman S, et al. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut. 2008;57:156–60.PubMedGoogle Scholar
  134. 134.
    Tamhankar AP, Peters JH, Portale G, et al. Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg. 2004;8:888–96.Google Scholar
  135. 135.
    Smout AJPM. The patient with GORD and chronically recurrent problems. Best Pract Res Clin Gastroenterol. 2007;21:365–78.PubMedGoogle Scholar
  136. 136.
    DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999;94:1434–42.PubMedGoogle Scholar
  137. 137.
    Katzka DA, Paoletti V, Leite L, et al. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol. 1996;91:2110–3.PubMedGoogle Scholar
  138. 138.
    Hirano I, Zhang Q, Pandolfino J, et al. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2005;3:1083–8.PubMedGoogle Scholar
  139. 139.
    Piper DW, Fenton BH. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut. 1965;6:506–8.PubMedGoogle Scholar
  140. 140.
    Tuttle SG, Rufin F, Bettarello A. The physiology of heartburn. Ann Intern Med. 1961;55:292–300.PubMedGoogle Scholar
  141. 141.
    Johnson LF, DeMeester TR. Twenty four hour pH monitoring of distal esophagus. Am J Gastroenterol. 1974;62:323–32.Google Scholar
  142. 142.
    Wenner J, Johnsson F, Johansson J, et al. Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol. 2005;40:768–74.PubMedGoogle Scholar
  143. 143.
    Zerbib F, des Varannes SB, Roman S, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther. 2005;22:1011–21.PubMedGoogle Scholar
  144. 144.
    Weiner GJ, Richter JE, Cooper JB, et al. The Symptom Index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358–61.Google Scholar
  145. 145.
    Lam HG, Breumelhof R, Roelofs JM, Van Berge Henegouwen GP, Smout AJ. What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci. 1994;39:402–9.Google Scholar
  146. 146.
    Breumelhof R, Smout AJPM. The Symptom Sensitivity Index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol. 1991;86:160–4.PubMedGoogle Scholar
  147. 147.
    Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology. 1994;107:1741–5.PubMedGoogle Scholar
  148. 148.
    Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut. 2005;54:1067–71.PubMedGoogle Scholar
  149. 149.
    Khan M, Santana J, Donnellan C, Preston C, Moayyedi P. Medical treatments in the short term management of reflux esophagitis. Cochrane Database Syst Rev. 2007;(2):CD003244.Google Scholar
  150. 150.
    Lundell L, Miettinen P, Myrvold HE, et al. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surg. 2007;94:198–203.PubMedGoogle Scholar
  151. 151.
    Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001;285:2331–8.PubMedGoogle Scholar
  152. 152.
    Jackson PG, Gleiber MA, Askari R, et al. Predictors of outcome in 100 consecutive laparoscopic antireflux procedures. Am J Surg. 2001;181:231–5.PubMedGoogle Scholar
  153. 153.
    Moayyedi P, Tally NJ. Gastro-oesophageal reflux disease. Lancet. 2006;367(9528):2086–100.PubMedGoogle Scholar
  154. 154.
    Cremonini F, Wise J, Moayyedi P, et al. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol. 2005;100:1226–32.PubMedGoogle Scholar
  155. 155.
    RC Ciriza de los, Garcia ML, Diez HA, et al. Role of stationary esophageal manometry in clinical practice. Manometric results in patients with gastroesophageal reflux, dysphagia or non-cardiac chest pain. Rev Esp Enferm Dig. 2004;96:606–8.Google Scholar
  156. 156.
    Dekel R, Pearson T, Wendel C, et al. Assessment of oesophageal motor function in patients with dysphagia or chest pain—the Clinical Outcomes Research Initiative experience. Aliment Pharmacol Ther. 2003;18:1083–9.PubMedGoogle Scholar
  157. 157.
    Wang WH, Huang JQ, Zheng GF, et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis. Arch Intern Med. 2005;165:1222–8.PubMedGoogle Scholar
  158. 158.
    Vaezi MF, Hicks DM, Abelson TI, et al. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1:333–44.PubMedGoogle Scholar
  159. 159.
    Field SK, Sutherland LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature. Chest. 1998;114:275–83.PubMedGoogle Scholar
  160. 160.
    Noordzij JP, Khidr A, Desper E, et al. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope. 2002;112:2192–5.PubMedGoogle Scholar
  161. 161.
    Eubanks TR, Omelanczuk PE, Maronian N, et al. Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux. J Gastrointest Surg. 2001;5:183–90; discussion 190–1.Google Scholar
  162. 162.
    Maldonado A, Diederich L, Castell DO, et al. Laryngopharyngeal reflux identified using a new catheter design: defining normal values and excluding artifacts. Laryngoscope. 2003;113:349–55.PubMedGoogle Scholar
  163. 163.
    Shaker R, Bardan E, Gu C, et al. Intrapharyngeal distribution of gastric acid refluxate. Laryngoscope. 2003;113:1182–91.PubMedGoogle Scholar
  164. 164.
    Ahmed T, Vaezi MF. The role of pH monitoring in extraesophageal gastroesophageal reflux disease. Gastrointest Endosc Clin N Am. 2005;15:319–31.PubMedGoogle Scholar
  165. 165.
    Netzer P, Gut A, Heer R, et al. Five-year audit of ambulatory 24-hour esophageal pH-manometry in clinical practice. Scand J Gastroenterol. 1999;34:676–82.PubMedGoogle Scholar
  166. 166.
    Zerbib F, Bruley Des Varannes S, Roman S, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian–French cohort of healthy subjects. Aliment Pharmacol Ther. 2005;22:1011–21.PubMedGoogle Scholar
  167. 167.
    Schnatz PF, Castell JA, Castell DO. Pulmonary symptoms associated with gastroesophageal refluxuse of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol. 1996;91:1715–8.PubMedGoogle Scholar
  168. 168.
    Grande L, Pujol A, Ros E, et al. Intraesophageal pH monitoring after breakfast + lunch in gastroesophageal reflux. J Clin Gastroenterol. 1988;10:373–6.PubMedGoogle Scholar
  169. 169.
    Garrean CP, Gonsalves N, Hirano I. Bravo pH testing on and off treatment with immediate-release omeprazole. Gastroenterol Hepatol. 2007;3:4–7.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of GastroenterologySheba Medical CenterRamat-GanIsrael

Personalised recommendations